GN-HEARING
GN Hearing, the global leader in hearing aid innovation, today unveils ReSound Key, a full essential hearing aid line-up that provides greater access to proven and award-winning hearing technology worldwide. Based on an advanced chip platform and GN’s Organic Hearing philosophy, ReSound Key promises clear, natural sound quality. It is also packed with the latest technology, such as rechargeable options and state-of-the-art streaming, so that more people can now stay connected to live life to the fullest.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210201005069/en/
Today, only one in five of those who could benefit from hearing aids are using themi , leaving a large proportion to miss out on life’s sounds, communicating with family, and socializing with friends. The long-awaited ReSound Key is set to make a huge difference to people with all types of hearing loss. People can boost their confidence and connect with others and the world during times of social isolation; all with clear sound and leading rechargeability that offers up to 30 hours of power from one charge. They can enjoy direct streaming using iOS and Android™ devices and state-of-the-art Bluetooth® Low Energy.
Not treating hearing loss comes at a personal cost, with implications for physical, social, emotional, and mental health.ii,iii,iv However, professional guidance is at hand, even remotely, thanks to the innovative telehealth solution, ReSound Assist Live. With this agile at-home service, hearing care professionals can program and adjust ReSound Key hearing aids via video consultations to help people grow with their hearing and nurture their relationships.
GN Hearing CEO and President, Gitte Aabo, explains: “At GN Hearing, we believe that everyone deserves great hearing. Treating hearing loss can radically transform lives, helping people to thrive and grow. The launch of ReSound Key gives more people access to the best care and professional guidance, which helps them feel more confident and stay in touch with others to participate fully in life.”
ReSound Key joins the groundbreaking ReSound ONETM with M&RIE* and ReSound LiNX Quattro™ in the strongest and broadest ReSound portfolio yet, which offers premium hearing solutions at all price levels. Now more people can benefit from the company’s long-standing Organic Hearing philosophy to connect with the world around them in the most intuitive and natural way, which is inspired by how the ear works and the natural ways we listen.
Working with intuitive apps, ReSound Key further enhances the individualized hearing experience and can connect to a range of wireless accessories for additional help in challenging listening situations. New integrated, streamlined fitting and software updates ensure a seamless first fit and customer satisfaction. These updates make it easier than ever to offer the ReSound portfolio for users to enjoy.
ReSound Key is available in 10 models, including the popular rechargeable Receiver-in-Ear (RIE) design, custom hearing aids, and Behind-the-Ear (BTE) options – even including high power and super power models for profound hearing loss. ReSound Key will roll out in markets around the world from February 1, 2021. The same technology and models are also available in the new Beltone Rely hearing aid portfolio.
For further information, visit the ReSound Newsroom and learn about the Organic Hearing philosophy. A ReSound Virtual Conference is hosted for hearing care professionals in the United States on February 2, 2021.
– ENDS –
NOTES TO EDITORS
About ReSound
ReSound hearing aids, available from leading hearing care professionals, continue to set worldwide standards for quality and intuitive technology to help people with hearing loss communicate better than ever before. ReSound was the first hearing aid brand to be Made for iPhone, bringing direct streaming from hearing aids into the iPhone era. It also pioneered the development of 2.4 GHz wireless technology and made it possible to receive advanced at-home hearing care during COVID-19. The recent introduction of a new class of hearing technology with ReSound ONE demonstrates that ReSound is the undisputed innovation leader putting people with hearing loss at the center. Featuring award winning technology, ReSound has been trusted for decades by people with hearing loss and their caregivers around the world.
About GN Group
The GN Group enables people to Hear More, Do More and Be More through its intelligent hearing, audio and video collaboration solutions. Inspired by people and driven by our innovation leadership, we leverage technological synergies between our hearing and audio divisions to deliver unique and increasingly individualized user experiences in our products and solutions.
150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound and video processing, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra, BlueParrott and FalCom in 100 countries. Founded in 1869, the GN Group employs 6,500 people and is listed on Nasdaq Copenhagen (GN.CO).
Visit our homepage GN.com, get to know our innovation and leadership , and connect with us on LinkedIn and Facebook .
*ReSound ONE introduced the world’s first full-featured hearing aid with M&RIE. Microphone and Receiver In Ear, for a truly individualized, more complete sound experience. ‘Full-featured’ means a microphone in the ear and two additional, standard directional microphones, directionality features and wireless audio streaming.
© 2021 GN Hearing A/S. All rights reserved. ReSound is a trademark of GN Hearing A/S. Beltone is a trademark of GN Hearing Care Corporation. Apple, the Apple logo, iPhone, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google LLC. Bluetooth word mark and logos are registered trademarks owned by Bluetooth SIG, Inc
i World Health Organization (WHO) 2020: https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss
ii Hearing loss and incident dementia. Lin et al 2011
iii The impact of communication impairments on the social relationships of older adults: Pathways to psychological well-being. Palmer et al 2019
iv Hearing loss and associated medical conditions among individuals 65 years and older. McKee et al 2018
View source version on businesswire.com: https://www.businesswire.com/news/home/20210201005069/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CSC Digital Brand Services Announces Integration into CrowdStrike Falcon Adversary Intelligence’s Recon to Accelerate Detection and Enforcement Against Malicious Domains15.9.2025 23:27:00 CEST | Press release
CSC, the world’s leading enterprise-class domain registrar and online brand protection provider, announced today at Fal.Con 2025 a new integration of CSC’s domain security offerings with the CrowdStrike Falcon® cybersecurity platform. The integration with Recon, a core capability within Falcon Adversary Intelligence, enables organizations to accelerate the detection and takedown of malicious domains, reducing exposure to phishing, fraud, and brand abuse. As cybercrime reaches unprecedented levels, adversaries are increasingly exploiting digital assets, brands, and domain name system (DNS) infrastructure. Traditional defenses often overlook domain portfolios, leaving organizations vulnerable to spoofing, impersonation, and account takeovers. CSC and CrowdStrike are uniting to close this gap with a comprehensive solution that integrates advanced threat intelligence, rapid detection, and global enforcement. Through this integration, clients can: Leverage the Recon capability in Falcon Adv
Celonis Debuts at No. 3 on the 2025 Fortune Future 5015.9.2025 22:58:00 CEST | Press release
Celonis, a global leader in Process Mining, today announced it has been named to No. 3 on the 2025 Fortune Future 50 list, recognized among the world’s most promising companies poised for long-term growth. This marks the company’s first appearance on the list alongside a prestigious group of global innovators, and underscores its leadership in enabling successful AI and business transformation through Process Intelligence. Published annually in collaboration with the Boston Consulting Group, the Fortune Future 50 evaluates more than 2,000 public companies to identify those best positioned for sustained growth based on a proprietary system analyzing market potential, innovation, strategy, and investment in the future. “Being named to the Fortune Future 50 is powerful validation of the mission we’ve been on since day one - to make processes work for people, companies and the planet,” said Alex Rinke, co-CEO and co-founder of Celonis. “This is truly just the beginning of seeing how Proces
ElevenLabs-Powered Chroma Awards Opens Call For Submissions, With November 3 Deadline15.9.2025 15:00:00 CEST | Press release
Creator-Led Global AI Film, Music Video, and Games CompetitionUniting the Global AI Creative Community Chroma Awards, a groundbreaking AI Film, Music Video, and Games competition organized by ElevenLabs, the leading AI audio research and product company, announced today that submissions are open for its inaugural competition, with a November 3 deadline. Competition participants can access free trials of AI tools provided by sponsors starting today at https://pack.chromaawards.com/. The Chroma Awards was established with the mission to educate, empower, and spotlight the next generation of artists and showcase how AI can empower human creativity. The competition is organized by ElevenLabs and presented by Google Cloud, Freepik, fal, Dreamina AI, and CapCut. “Through this initiative we hope to unite creators, communities, and companies across the world to bring emerging technology and creative talent together in dialogue,” said Matty Shimura, Chroma Awards. “We’re incredibly grateful to
33 Innovators Join Morgan Stanley Inclusive & Sustainable Ventures Cohort15.9.2025 14:08:00 CEST | Press release
Accelerator’s expanded focus includes sustainable solutions and support for nonprofits 2025 cohort comprised of 33 early-stage innovators from the Americas and EMEA Five-month program to provide founders with $250,000 (£250,000), as well as mentorship and growth resources Morgan Stanley (NYSE: MS) today announced the global cohort of its Inclusive & Sustainable Ventures (MSISV). With founders from the Americas and Europe, the Middle East and Africa (EMEA), the 2025 MSISV cohort will support 29 startups in its Lab and four emerging nonprofits in its Collaborative, two in-house accelerators that will run over the next five months. Selected from thousands of applications, the 33 organizations will engage in a tailored entrepreneurship curriculum and receive mentorship and business-growth resources from Morgan Stanley’s ecosystem of internal and external partners. The firm will invest $250,000 (£250,000 in EMEA) in each startup and provide each nonprofit with a $250,000 grant. “Morgan Stan
Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas15.9.2025 14:00:00 CEST | Press release
Researchers aim to identify cellular circuit mechanisms and generate a dataset to fuel AI-driven foundational research of lung biology Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse Biosciences’ GigaLab platform. Using a human lung ex-vivo tissue slice culture model from normal control donor lungs as well as explant lung tissues from patients with chronic lung disease, the study aims to identify novel targets and cell circuits in lung health and disease by characterizing disease-specific responses of cells to 900 pharmacological interventions. Prof Herbert Schiller, Director of Helmholtz Munich’s Precision Regenerative Medicine Research Unit, and a leading researcher on lung biology and disease, will head this ambitious initiative. “Measuring the effects of drug treatments at single cell level directly in human lung tissue at scale, will help us to find strategies that imp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom